Warning! GuruFocus detected
2 Severe warning signs
with VMD.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Viemed Healthcare Inc
NAICS : 334510
SIC : 3359
ISIN : CA92663R1055
Share Class Description:
VMD: Ordinary SharesCompare
Compare
Traded in other countries / regions
VMD.USAVMD.CanadaVIJ.Germany Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2018-01-03Description
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.56 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 20.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.31 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 24.1 | |||||
| 3-Year EBITDA Growth Rate | 20.5 | |||||
| 3-Year EPS without NRI Growth Rate | 2.7 | |||||
| 3-Year FCF Growth Rate | -22.2 | |||||
| 3-Year Book Growth Rate | 12 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 35.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.26 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.39 | |||||
| 9-Day RSI | 34.04 | |||||
| 14-Day RSI | 36.82 | |||||
| 3-1 Month Momentum % | -2.51 | |||||
| 6-1 Month Momentum % | 6.14 | |||||
| 12-1 Month Momentum % | -18.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 0.47 | |||||
| Days Inventory | 17.66 | |||||
| Days Sales Outstanding | 39.7 | |||||
| Days Payable | 36.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | 0.54 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.4 | |||||
| Operating Margin % | 7.13 | |||||
| Net Margin % | 5.02 | |||||
| FCF Margin % | 0.59 | |||||
| ROE % | 9.3 | |||||
| ROA % | 6.87 | |||||
| ROIC % | 8.66 | |||||
| 3-Year ROIIC % | 4.53 | |||||
| ROC (Joel Greenblatt) % | 22.03 | |||||
| ROCE % | 13.42 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.86 | |||||
| Forward PE Ratio | 18.15 | |||||
| PE Ratio without NRI | 29.19 | |||||
| Price-to-Owner-Earnings | 18.25 | |||||
| PEG Ratio | 1.92 | |||||
| PS Ratio | 1.31 | |||||
| PB Ratio | 2.15 | |||||
| Price-to-Tangible-Book | 2.92 | |||||
| Price-to-Free-Cash-Flow | 226.87 | |||||
| Price-to-Operating-Cash-Flow | 7.58 | |||||
| EV-to-EBIT | 16.1 | |||||
| EV-to-EBITDA | 6.58 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-Forward-Revenue | 1.39 | |||||
| EV-to-FCF | 214.05 | |||||
| Price-to-GF-Value | 0.69 | |||||
| Price-to-Projected-FCF | 1.19 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.34 | |||||
| Price-to-Graham-Number | 1.95 | |||||
| Price-to-Net-Current-Asset-Value | 40.33 | |||||
| Earnings Yield (Greenblatt) % | 6.21 | |||||
| FCF Yield % | 0.46 | |||||
| Forward Rate of Return (Yacktman) % | 16.03 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viemed Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 224.257 | ||
| EPS (TTM) ($) | 0.28 | ||
| Beta | 1.35 | ||
| 3-Year Sharpe Ratio | 0.64 | ||
| 3-Year Sortino Ratio | 1.22 | ||
| Volatility % | 33.53 | ||
| 14-Day RSI | 36.82 | ||
| 14-Day ATR ($) | 0.253985 | ||
| 20-Day SMA ($) | 7.607 | ||
| 12-1 Month Momentum % | -18.02 | ||
| 52-Week Range ($) | 6.214 - 9.81 | ||
| Shares Outstanding (Mil) | 39.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Viemed Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Viemed Healthcare Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Viemed Healthcare Inc Frequently Asked Questions
What is Viemed Healthcare Inc(VMD)'s stock price today?
The current price of VMD is $7.26. The 52 week high of VMD is $9.81 and 52 week low is $6.21.
When is next earnings date of Viemed Healthcare Inc(VMD)?
The next earnings date of Viemed Healthcare Inc(VMD) is 2025-05-07 Est..
Does Viemed Healthcare Inc(VMD) pay dividends? If so, how much?
Viemed Healthcare Inc(VMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers